Trials / Unknown
UnknownNCT03643172
Terminator 2 Register
Termination of Nucleos(t)Ide Analogue Therapy of HBeAg Negative Chronic Hepatitis B - 2nd Register Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
All patients with chronic HBeAg negative hepatitis B treated with nucleos(t)ide analogues, who discontinue treatment based in the criteria outlined in the EASL hepatitis B guidelines shall be included in the present study. The aim is to evaluate the clinical outcome (virological relapse, HBsAg decline) and associated virological and immunological parameters.
Conditions
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2020-07-01
- Completion
- 2024-07-01
- First posted
- 2018-08-22
- Last updated
- 2019-02-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03643172. Inclusion in this directory is not an endorsement.